Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 45

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 45
---
 thereby, including the Divestiture; and |

| • |     | the fiduciary duties of Aadi’s board of directors in light of the foregoing. |

Recommendation of Aadi’s Board of Directors —PIPE Financing(see page [●]) After careful consideration and following input from Aadi’s financial and legal advisors, Aadi’s board of directors has unanimously (i) determined that the Subscription Agreement, the Registration Rights Agreement and the Pre-FundedWarrant, and all the transactions contemplated thereby, including the PIPE Financing, were fair, advisable and in the best interests of Aadi and its stockholders; (ii) approved in all respects the Subscription Agreement, the Registration Rights Agreement, and the Pre-FundedWarrant, and all the transactions contemplated thereby, including the PIPE Financing; (iii) determined that it was advisable and in the bests interests of Aadi and its stockholders to enter into the License Agreement; (iv) approved in all respects the form, terms and provisions of the License Agreement; and (v) recommended that stockholders for “FOR” the PIPE Financing. Aadi’s board of directors unanimously recommends that the Aadi stockholders approve the PIPE Financing and vote “FOR” the PIPE Financing Proposal. Certain factors considered by our board of directors in making such unanimous determination and approval are described in the section entitled “ The PIPE Financing and License Agreement—Reasons for the PIPE Financing and the License Agreement and Recommendation of our Board of Directors.” Interests of Aadi’s Directors and Executive Officers in the PIPE Financing(see page [●]) Certain directors, affiliated funds of directors, and an executive officer of Aadi have interests in the PIPE Financing that are different from, or in addition to, the interests of Aadi stockholders generally. Certain directors, affiliated funds of directors, and an executive officer of Aadi entered into the Subscription Agreement in connection with the PIPE Financing, and committed to purchase an aggregate of 4,577,000 shares of common stock and 8,333,000 Pre-Funded Warrants.The PIPE Investors include entities that are related to Casey Castelein, M.D., Anupam Dalal, M.D., Behzad Aghazadeh, Ph.D. and Baiteng Zhao, who serve on our board of

- 30 -

directors, as well as an executive officer for the year ended December 31, 2024, Bryan Ball. See the section entitled “Certain Relationships and Related Party Transactions” for
more information about such purchases